180 Life Sciences (ATNF) Short Interest Ratio & Short Volume

Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 144,800 shares of ATNF short. 2.61% of 180 Life Sciences' shares are currently sold short. Learn More on 180 Life Sciences' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 180 Life Sciences: Citadel Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.61% of 180 Life Sciences' floating shares are currently sold short.

180 Life Sciences saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 144,800 shares, a decrease of 77.1% from the previous total of 632,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

180 Life Sciences currently has issued a total of 5,320,000 shares. Some of 180 Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 180 Life Sciences currently has a public float of 5,550,000 shares.

2.61% of 180 Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to 180 Life Sciences: Aridis Pharmaceuticals, Inc. (5.56%), Adial Pharmaceuticals, Inc. (6.21%), Aditxt, Inc. (11.29%), Petros Pharmaceuticals, Inc. (1.71%), Dermata Therapeutics, Inc. (0.02%), Agile Therapeutics, Inc. (0.58%), Phio Pharmaceuticals Corp. (0.68%), Bellicum Pharmaceuticals, Inc. (8.52%), Evoke Pharma, Inc. (0.11%), Cyclacel Pharmaceuticals, Inc. (3.97%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks.

Short selling ATNF is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. ATNF shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNF, twice per month. The most recent reporting period available is August, 31 2023.